BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18359758)

  • 1. Network meta-analysis of antiplatelet treatments for secondary stroke prevention.
    Baumgartner RW
    Eur Heart J; 2008 May; 29(9):1082-3. PubMed ID: 18359758
    [No Abstract]   [Full Text] [Related]  

  • 2. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
    Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; CantĂș C; Leyva A; Murillo L; Villarreal J; Vargas RD; AlegrĂ­a MA; Merino JG; Romano J;
    Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the finding of the PROFESS study consistent with predictions of network meta-analysis?
    Lam SK; Owen A
    Eur Heart J; 2008 Oct; 29(20):2580. PubMed ID: 18799521
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management.
    Biller J
    J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing and treating stroke and transient ischemic attack.
    DeFaria Yeh D; Waters DD
    Am J Cardiol; 2008 Jan; 101(2):270-3. PubMed ID: 18178421
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale.
    Ovbiagele B
    J Emerg Med; 2008 May; 34(4):389-96. PubMed ID: 18207691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anticoagulants or antiplatelet aggregating drugs in the prevention of ischemic stroke.
    Adams HP
    Adv Intern Med; 1995; 40():503-31. PubMed ID: 7747656
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke prevention.
    Gress DR; Singh V
    Phys Med Rehabil Clin N Am; 1999 Nov; 10(4):827-38, viii. PubMed ID: 10573710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of stroke.
    MacDougall NJ; Amarasinghe S; Muir KW
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1103-15. PubMed ID: 19764863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of antiplatelet drugs in ischaemic stroke prevention--update on new trials.
    Rother J
    Cerebrovasc Dis; 2007; 24 Suppl 1():112-5. PubMed ID: 17971646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulants and non-cardioembolic stroke prevention.
    Schachter ME; Tran HA; Anand SS
    Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prevention.
    Weir E
    CMAJ; 2005 Aug; 173(4):363. PubMed ID: 16103506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.